Industry Insights
-
Accountability Gaps Can Break Clinical Supply Contracts
8/24/2026
Contract gaps can create clinical supply failures when responsibilities differ across agreements. See how aligning obligations can prevent costly disputes, delays, and risks.
-
Receptor Occupancy In The Era Of Multispecific Therapeutics
8/21/2026
Receptor occupancy studies face new challenges as multispecific therapeutics introduce complex target engagement, receptor trafficking, cellular interactions, and assay interpretation considerations.
-
'How Do You Feel?': Designing A Cardiac Trial With A Patient-Reported Primary Endpoint
8/21/2026
Imbria Pharmaceuticals' Albert Kim, MD, Ph.D., shares why PROs are the point of the company's FORTITUDE-HCM trial for patients with non-obstructive hypertrophic cardiomyopathy.
-
Sustainable Patient Engagement: Your Enrollment And Representation Depend On It
8/21/2026
Early and ongoing patient engagement is a crucial component to staving off recruitment trouble and securing proper patient representation. Boehringer Ingelheim's Karen Correa, Ph.D., explains how.
-
Building The Execution Architecture For Real-World Data To Have Real-World Impact
8/20/2026
RWE's next challenge is execution. Learn how life sciences orgns can turn evidence into sustained business and clinical impact.
-
The Reality Of Clinical Research Federal Funding Cuts
8/20/2026
Although the most catastrophic federal funding cuts didn't come to fruition, Pamela Garzone discusses where some impacts are being felt now and will be felt for years to come.
-
Stock Options: Choosing The Right Viral Inoculum For An Early-Phase Norovirus Trial
8/20/2026
Viral stock can make or break a norovirus challenge study. Cocrystal Pharma's Sam Lee explains why inoculum quality, infectivity, and availability matter.
-
Running Compliant Studies Without Enterprise EDC Overhead
8/19/2026
Low-complexity medical device and IVD studies often fall between enterprise EDC systems and spreadsheets. This webinar shows how a compliant, audit-ready alternative works in practice.
-
From Hype To Health: The Three Jobs Sword Made Its Clinical Evidence Do
8/19/2026
A long-term strategy for turning clinical evidence into clinician trust, standard-of-care status, and payer reimbursement for digital care.
-
Everyone Is A Consultant Now
8/19/2026
Jon Newton argues clinical research’s “vanishing middle” is giving rise to a more flexible workforce of consultants, specialists, and boutique firms.